#IPRs
India's music publishing market keeps growing. IPRS collected ₹804.5 crore and paid ₹628.3 crore in royalties in FY2025–26.
Read more-https://tinyurl.com/hrhtxfry

#gbmpub #gbmpublishing #MusicPublishing #IPRS #MusicRoyalties #Songwriters #IndianMusic #MusicRights
November 12, 2026 at 10:03 PM
November 11, 2026 at 5:16 PM
November 8, 2026 at 3:35 PM
How to resolve IPRS Cloud API error codes for B2B registry SaaS? — https://iprs.cloud/knowledge/how_to_resolve_iprs_cloud_api_error_codes_for_b2b_registry_saas.php
November 8, 2026 at 3:36 PM
Distinctions I wouldn't expect most journalists to understand/care and it varies from admin to admin and SECDEF to SECDEF but you know J5 JSP would run the SECDEF IPRs, the [country] readiness reviews, and work with *coordinating authorities* to develop globally integrated base plans or frameworks
October 29, 2026 at 5:59 PM
www.youtube.com
October 3, 2026 at 3:08 PM
Discretionary denial can prevent large infringers from abusing IPRs to suppress smaller competitors and discourage patent enforcement.
Save What Matters
Curate Feeds | Make Collections | Customize Email Briefs
briefly.co
September 30, 2026 at 7:08 PM
Discretionary denial can prevent large infringers from abusing IPRs to suppress smaller competitors and discourage patent enforcement.
Save What Matters
Curate Feeds | Make Collections | Customize Email Briefs
briefly.co
September 30, 2026 at 7:08 PM
USPTO Institutes Four IPRs Challenging Janssen’s Golimumab Method-of-Treatment Patents
USPTO Institutes Four IPRs Challenging Janssen’s Golimumab Method-of-Treatment Patents
On September 9, 2026, the U.S. Patent and Trademark Office issued a Notice of Decisions on Institution granting institution in four inter partes...
www.jdsupra.com
September 29, 2026 at 7:12 PM
USPTO Institutes Four IPRs Challenging Janssen’s Golimumab Method-of-Treatment Patents
USPTO Institutes Four IPRs Challenging Janssen’s Golimumab Method-of-Treatment Patents
On September 9, 2026, the U.S. Patent and Trademark Office issued a Notice of Decisions on Institution granting institution in four inter partes...
www.jdsupra.com
September 29, 2026 at 7:12 PM
USPTO Institutes Four IPRs Challenging Janssen’s Golimumab Method-of-Treatment Patents
USPTO Institutes Four IPRs Challenging Janssen’s Golimumab Method-of-Treatment Patents
On September 9, 2026, the U.S. Patent and Trademark Office issued a Notice of Decisions on Institution granting institution in four inter partes...
www.jdsupra.com
September 29, 2026 at 7:12 PM
Die Online-Vorlesungsreihe "Political Phenomenology in Debate" geht im Wintersemester 2026/27 in eine neue Runde. Unter dem Titel "Resistance(s)" versammelt die gemeinsam mit dem Intercontinental Phenomenology Research Seminar (IPRS) ausgerichtete Reihe sechs... https://www.theorieblog.de/?p=31176
September 28, 2026 at 10:00 AM
🎵😁

Leniwe popołudnie :)

www.youtube.com/watch?v=iPRS...
www.youtube.com
September 26, 2026 at 3:34 PM
Yes, but more broadly, a political EU and our way of framing it is through common rules. We have to set standards on a variety of topics, such as IPRs, AI commons, production circularity, etc.
September 22, 2026 at 6:01 PM
If I got to redo IPRs, I’d keep the lower invalidity threshold, no restrictions on what kind of art you can use, but by submitting to it you *also* have to submit to the PTAB making a binding infringement determination as to accused products if patentee elects, district court only about dmgs
September 22, 2026 at 2:36 PM
🎵😎

Yeba*** Pi$, szkoda na nich weekendu, posłuchajcie muzy :))

www.youtube.com/watch?v=iPRS...
www.youtube.com
September 19, 2026 at 4:19 PM
Director Terminates IPRs for Sotera Violations and the District Court Strikes Invalidity Contentions
Director Terminates IPRs for Sotera Violations and the District Court Strikes Invalidity Contentions
On May 12, 2026, the Director of the United States Patent and Trademark Office (“USPTO”), John Squires, granted a patent owner’s motion to...
www.jdsupra.com
September 18, 2026 at 7:22 PM
With Phil Malone and the Juelsgaard IP & Innovation Clinic at Stanford Law, I filed an amicus brief on behalf of 38 law professors urging the Supreme Court to take up the PTO's effort to prevent meritorious IPRs from being considered on the merits

www.supremecourt.gov/DocketPDF/26...
www.supremecourt.gov
September 16, 2026 at 8:01 PM
Keytruda Qlex™ Updates: PTAB Finds Halozyme ’520 PH20 Patent Unpatentable and Institutes Three IPRs
Keytruda Qlex™ Updates: PTAB Finds Halozyme ’520 PH20 Patent Unpatentable and Institutes Three IPRs
On September 1, 2026, the Patent Trial and Appeal Board (“PTAB”) issued a Final Written Decision (“FWD”) in PGR2025-00017 finding all remaining...
www.jdsupra.com
September 16, 2026 at 4:43 PM
We also had posts on copyright strikes and intermediary due diligence, the ongoing Ribociclib litigation before the Kerala High Court, the paper trail in IPRS v. Hotel Appolo, and the Delhi High Court’s evolving approach towards well-known marks and TM oppositions. (2/3)
September 15, 2026 at 9:57 AM
PTAB Director Institutes Four Simponi® / Simponi Aria® (golimumab) IPRs
PTAB Director Institutes Four Simponi® / Simponi Aria® (golimumab) IPRs
On September 9, 2026, the Director of the Patent Trial and Appeal Board (PTAB) instituted four IPRs brought by Accord and Bio-Thera against...
www.jdsupra.com
September 14, 2026 at 5:40 PM
PTAB Director Institutes Four Simponi® / Simponi Aria® (golimumab) IPRs
PTAB Director Institutes Four Simponi® / Simponi Aria® (golimumab) IPRs
On September 9, 2026, the Director of the Patent Trial and Appeal Board (PTAB) instituted four IPRs brought by Accord and Bio-Thera against...
www.jdsupra.com
September 14, 2026 at 5:40 PM